Simona Boccardo

1.7k total citations
37 papers, 1.1k citations indexed

About

Simona Boccardo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Simona Boccardo has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Simona Boccardo's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Peptidase Inhibition and Analysis (6 papers). Simona Boccardo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (7 papers) and Peptidase Inhibition and Analysis (6 papers). Simona Boccardo collaborates with scholars based in Italy, United Kingdom and United States. Simona Boccardo's co-authors include Sandra Salvi, Francesco Grossi, Maria Giovanna Dal Bello, Mauro Truini, Simona Coco, Carlo Genova, Angela Alama, Giovanni Rossi, Marco Tagliamento and Vincenzo Fontana and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

Simona Boccardo

37 papers receiving 1.1k citations

Peers

Simona Boccardo
Pradip De United States
Heather J. Dalton United States
Maria De Mol Belgium
Lucy Ireland United Kingdom
Nam Y. Lee United States
Limei Qu China
Simona Boccardo
Citations per year, relative to Simona Boccardo Simona Boccardo (= 1×) peers Adrian M. Seifert

Countries citing papers authored by Simona Boccardo

Since Specialization
Citations

This map shows the geographic impact of Simona Boccardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Boccardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Boccardo more than expected).

Fields of papers citing papers by Simona Boccardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Boccardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Boccardo. The network helps show where Simona Boccardo may publish in the future.

Co-authorship network of co-authors of Simona Boccardo

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Boccardo. A scholar is included among the top collaborators of Simona Boccardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Boccardo. Simona Boccardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fabbri, Giulia, et al.. (2024). Dynamics of Mucosal Integration of Machined versus Anodized Titanium Implants. Journal of Dental Research. 104(3). 270–279. 1 indexed citations
2.
Rossi, Giovanni, Lodovica Zullo, Luigi Cerbone, et al.. (2020). ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium. Expert Opinion on Pharmacotherapy. 21(6). 679–686. 2 indexed citations
3.
Coco, Simona, Simona Boccardo, Marco Mora, et al.. (2020). Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer. Clinical Breast Cancer. 21(3). 218–230.e6. 2 indexed citations
4.
Baio, Gabriella, Marina Fabbi, Michele Cilli, et al.. (2020). Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors. PLoS ONE. 15(9). e0224414–e0224414. 4 indexed citations
5.
Alama, Angela, Simona Coco, Carlo Genova, et al.. (2019). Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. Journal of Clinical Medicine. 8(7). 1011–1011. 45 indexed citations
6.
Tagliamento, Marco, Carlo Genova, Giovanni Rossi, et al.. (2019). Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds. Expert Opinion on Investigational Drugs. 28(6). 513–523. 22 indexed citations
7.
Genova, Carlo, Simona Boccardo, Marco Mora, et al.. (2019). Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab. Journal of Clinical Medicine. 8(10). 1566–1566. 23 indexed citations
8.
Coco, Simona, Silvia Bonfiglio, Davide Cittaro, et al.. (2019). Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer. Cancers. 11(4). 441–441. 3 indexed citations
9.
Genova, Carlo, Gemma Rossi, Aldo Pezzuto, et al.. (2019). P2.14-02 Interim Survival Analysis of Gefitinib Plus Vinorelbine in Advanced EGFR-Mutant Non-Small Cell Lung Cancer (Genoa Trial). Journal of Thoracic Oncology. 14(10). S829–S830. 2 indexed citations
10.
Bello, Maria Giovanna Dal, Rosangela Filiberti, Angela Alama, et al.. (2019). The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. Journal of Translational Medicine. 17(1). 74–74. 124 indexed citations
11.
Rossi, Giovanni, Angela Alama, Carlo Genova, et al.. (2018). The evolving role of pemetrexed disodium for the treatment of non-small cell lung cancer. Expert Opinion on Pharmacotherapy. 19(17). 1969–1976. 17 indexed citations
12.
Tagliamento, Marco, Carlo Genova, Erika Rijavec, et al.. (2018). Afatinib and Erlotinib in the treatment of squamous-cell lung cancer. Expert Opinion on Pharmacotherapy. 19(18). 2055–2062. 27 indexed citations
13.
Cattrini, Carlo, A. Rubagotti, Pier Vitale Nuzzo, et al.. (2018). Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical Outcome. Clinical Genitourinary Cancer. 16(6). e1257–e1265. 11 indexed citations
14.
Nuzzo, Pier Vitale, et al.. (2015). Prognostic value of periostin (PN) expression in early breast cancer (BCa): Long-term mortality outcomes. Annals of Oncology. 26. iii15–iii15. 1 indexed citations
15.
Laurent, Stefania, Paola Queirolo, Silvia Boero, et al.. (2013). The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production. Journal of Translational Medicine. 11(1). 108–108. 129 indexed citations
16.
Puntoni, Matteo, Alessandra Argusti, C. Crosta, et al.. (2012). A Randomized, Placebo-Controlled, Preoperative Trial of Allopurinol in Subjects with Colorectal Adenoma. Cancer Prevention Research. 6(2). 74–81. 14 indexed citations
17.
Salvi, Sandra, Vincenzo Fontana, Simona Boccardo, et al.. (2012). Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer. Cancer Immunology Immunotherapy. 61(9). 1463–1472. 111 indexed citations
18.
Gangemi, Rosaria, Valentina Mirisola, Gaia Barisione, et al.. (2012). Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression. PLoS ONE. 7(1). e29989–e29989. 68 indexed citations
19.
Grosso, Federica, Simona Coco, Paola Scaruffi, et al.. (2011). Role of CXCL13-CXCR5 Crosstalk Between Malignant Neuroblastoma Cells and Schwannian Stromal Cells in Neuroblastic Tumors. Molecular Cancer Research. 9(7). 815–823. 26 indexed citations
20.
Tasso, Roberta, Andrea Augello, Simona Boccardo, et al.. (2009). Recruitment of a Host's Osteoprogenitor Cells Using Exogenous Mesenchymal Stem Cells Seeded on Porous Ceramic. Tissue Engineering Part A. 15(8). 2203–2212. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026